1516 related articles for article (PubMed ID: 10777209)
1. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
2. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
3. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer.
De Cesare D; Vallone D; Caracciolo A; Sassone-Corsi P; Nerlov C; Verde P
Oncogene; 1995 Jul; 11(2):365-76. PubMed ID: 7624151
[TBL] [Abstract][Full Text] [Related]
4. Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family and modulate its transcriptional activity.
Chatton B; Bocco JL; Goetz J; Gaire M; Lutz Y; Kedinger C
Oncogene; 1994 Feb; 9(2):375-85. PubMed ID: 8290251
[TBL] [Abstract][Full Text] [Related]
5. B-ATF: a novel human bZIP protein that associates with members of the AP-1 transcription factor family.
Dorsey MJ; Tae HJ; Sollenberger KG; Mascarenhas NT; Johansen LM; Taparowsky EJ
Oncogene; 1995 Dec; 11(11):2255-65. PubMed ID: 8570175
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of a dominant-negative mutant of c-Jun.
Brown PH; Chen TK; Birrer MJ
Oncogene; 1994 Mar; 9(3):791-9. PubMed ID: 8108121
[TBL] [Abstract][Full Text] [Related]
7. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
[TBL] [Abstract][Full Text] [Related]
9. Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis.
van Dam H; Castellazzi M
Oncogene; 2001 Apr; 20(19):2453-64. PubMed ID: 11402340
[TBL] [Abstract][Full Text] [Related]
10. Isolation of novel, transcriptionally active AP-1 binding sites: implications for cellular transformation.
Hawker KL; Vass JK; Ozanne BW
Oncogene; 1996 Jul; 13(2):283-92. PubMed ID: 8710367
[TBL] [Abstract][Full Text] [Related]
11. Analysis of dimerization and DNA binding functions in Fos and Jun by domain-swapping: involvement of residues outside the leucine zipper/basic region.
Cohen DR; Curran T
Oncogene; 1990 Jun; 5(6):929-39. PubMed ID: 2113670
[TBL] [Abstract][Full Text] [Related]
12. Coupling of folding and DNA-binding in the bZIP domains of Jun-Fos heterodimeric transcription factor.
Seldeen KL; McDonald CB; Deegan BJ; Farooq A
Arch Biochem Biophys; 2008 May; 473(1):48-60. PubMed ID: 18316037
[TBL] [Abstract][Full Text] [Related]
13. CRE DNA binding proteins bind to the AP-1 target sequence and suppress AP-1 transcriptional activity in mouse keratinocytes.
Rutberg SE; Adams TL; Olive M; Alexander N; Vinson C; Yuspa SH
Oncogene; 1999 Feb; 18(8):1569-79. PubMed ID: 10102627
[TBL] [Abstract][Full Text] [Related]
14. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
[TBL] [Abstract][Full Text] [Related]
15. Suppression of oncogene-induced transformation by a deletion mutant of c-jun.
Brown PH; Alani R; Preis LH; Szabo E; Birrer MJ
Oncogene; 1993 Apr; 8(4):877-86. PubMed ID: 8455942
[TBL] [Abstract][Full Text] [Related]
16. Partial oncogenic transformation of chicken embryo fibroblasts by Jun dimerization protein 2, a negative regulator of TRE- and CRE-dependent transcription.
Blazek E; Wasmer S; Kruse U; Aronheim A; Aoki M; Vogt PK
Oncogene; 2003 Apr; 22(14):2151-9. PubMed ID: 12687017
[TBL] [Abstract][Full Text] [Related]
17. Successive occupancy by immediate early transcriptional factors of the tyrosine hydroxylase gene TRE and CRE sites in PACAP-stimulated PC12 pheochromocytoma cells.
Yukimasa N; Isobe K; Nagai H; Takuwa Y; Nakai T
Neuropeptides; 1999 Dec; 33(6):475-82. PubMed ID: 10657527
[TBL] [Abstract][Full Text] [Related]
18. The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1.
Frank RC; Sun X; Berguido FJ; Jakubowiak A; Nimer SD
Oncogene; 1999 Mar; 18(9):1701-10. PubMed ID: 10208431
[TBL] [Abstract][Full Text] [Related]
19. fos-jun Conspiracy: implications for the cell.
Verma IM; Ransone LJ; Visvader J; Sassone-Corsi P; Lamph WW
Princess Takamatsu Symp; 1989; 20():119-26. PubMed ID: 2518685
[TBL] [Abstract][Full Text] [Related]
20. Structural determinants outside of the leucine zipper influence the interactions of CREB and ATF-2: interaction of CREB with ATF-2 blocks E1a-ATF-2 complex formation.
Abdel-Hafiz HA; Chen CY; Marcell T; Kroll DJ; Hoeffler JP
Oncogene; 1993 May; 8(5):1161-74. PubMed ID: 8479741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]